Harvard Bioscience News

News on Harvard Bioscience (Ticker: HBIO) continually updated from thousands of sources around the net.

Monday Apr 30 | GlobeNewswire

Harvard Bioscience, Inc. Schedules First Quarter 2012 Conference Call for May 3, 2012

Harvard Bioscience, Inc. , a global developer, manufacturer and marketer of a broad range of specialized products used to advance life science research and regenerative medicine, will announce results for the first quarter ended March 31, 2012 before market trading hours on Thursday, May 3, 2012.

Comment?

Tue Mar 06, 2012

Business Journal

Harvard Bioscience tracheal transplant patient dies

Harvard Bioscience Inc. has disclosed that Christopher Lyle, the recipient of the second-ever tracheal transplant using a synthetic tissue-engineered windpipe.

Comment?

Business Journal

Harvard Bioscience tracheal transplant patient dies

The windpipe was regenerated in a Harvard Bioscience InBreath Bioreactor. In a statement released Tuesday, the Holliston, Mass.-based company said it was not yet clear why Lyles had died.

Comment?

Tue Feb 28, 2012

PR-inside.com

SADIF Analytics releases new summary due diligence reports for American stocks

Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering the following companies: Report Summary for: Blyth, Inc.

Comment?

Tue Feb 07, 2012

GlobeNewswire

Harvard Bioscience, Inc. Acquires AHN

Harvard Bioscience, Inc. , a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of AHN Biotechnologie GmbH through its wholly owned Biochrom Ltd.

Comment?